Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471336 · ClinicalTrials.gov registry record · NA
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05471336 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT05471336, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The research team plans to administer trophic enteral feeds to infants with Neonatal Encephalopathy that are undergoing therapeutic hypothermia. The team will monitor splanchnic NIRS values and compare these values to a group of historic infants who underwent hypothermia but did not receive feeds, to investigate whether there may be a range of values that can predict safe feeding. The team will also look at some clinical outcomes including feeding tolerance, time to achieve full enteral feeds, infection rates, length of hospital stay.
Interventions
- PROCEDURE Enteral Feeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2024-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05471336
The ClinicalTrials.gov registry entry for NCT05471336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enteral Feeding is the first listed.
NCT05471336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05471336 about?
NCT05471336 is a clinical study titled "Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)". The research team plans to administer trophic enteral feeds to infants with Neonatal Encephalopathy that are undergoing therapeutic hypothermia. The team will monitor splanchnic NIRS values and compare these values to a group of historic infants who underwent hypothermia but did not receive feeds, t...
What is the current status of trial NCT05471336?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-09. Estimated completion is 2024-03-14.
What interventions are being tested in trial NCT05471336?
The interventions under investigation include: Enteral Feeding (PROCEDURE).
Who is sponsoring clinical trial NCT05471336?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.